Genetic engineering can be termed as the manipulation of genes of an organism or species for enhancing its abilities. The technology is used by pharmaceutical and biotechnology companies and by clinical research organizations. In medicine, gene therapy is the most widely used application for the treatment of cancer and other infectious diseases.
The global Genetic Engineering market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The extensive use of various technologies such as CRISPR/Cas9, TALEN, and ZNF in gene therapy for different genetic disorders and terminal illnesses is likely to be one of the primary drivers for the growth of this market.
This report aims to provide a comprehensive presentation of the global market for Genetic Engineering, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Engineering.
Report Scope
The Genetic Engineering market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genetic Engineering market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Engineering companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Âé¶¹Ô´´ Segmentation
By Company
Thermo Fisher Scientific
GenScript
Amgen
Genentech
Merck
Horizon Discovery Group
Sangamo Therapeutics
Transposagen Biopharmaceuticals
OriGene Technologies
Segment by Type
Artificial Selection
Cloning
Gene Splicing
Others
Segment by Application
Agriculture
BT - Cotton
Golden Rice
Forensic Science
Medical
Recombinant Proteins
Recombinant Antibodies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genetic Engineering companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Genetic Engineering Âé¶¹Ô´´ Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Artificial Selection
1.2.3 Cloning
1.2.4 Gene Splicing
1.2.5 Others
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Genetic Engineering Âé¶¹Ô´´ Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Agriculture
1.3.3 BT - Cotton
1.3.4 Golden Rice
1.3.5 Forensic Science
1.3.6 Medical
1.3.7 Recombinant Proteins
1.3.8 Recombinant Antibodies
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genetic Engineering Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Genetic Engineering Growth Trends by Region
2.2.1 Global Genetic Engineering Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Genetic Engineering Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Genetic Engineering Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Genetic Engineering Âé¶¹Ô´´ Dynamics
2.3.1 Genetic Engineering Industry Trends
2.3.2 Genetic Engineering Âé¶¹Ô´´ Drivers
2.3.3 Genetic Engineering Âé¶¹Ô´´ Challenges
2.3.4 Genetic Engineering Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genetic Engineering Players by Revenue
3.1.1 Global Top Genetic Engineering Players by Revenue (2019-2024)
3.1.2 Global Genetic Engineering Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Genetic Engineering Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genetic Engineering Revenue
3.4 Global Genetic Engineering Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Genetic Engineering Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Engineering Revenue in 2023
3.5 Genetic Engineering Key Players Head office and Area Served
3.6 Key Players Genetic Engineering Product Solution and Service
3.7 Date of Enter into Genetic Engineering Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Genetic Engineering Breakdown Data by Type
4.1 Global Genetic Engineering Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Genetic Engineering Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Genetic Engineering Breakdown Data by Application
5.1 Global Genetic Engineering Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Genetic Engineering Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Genetic Engineering Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Genetic Engineering Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Genetic Engineering Âé¶¹Ô´´ Size by Country (2019-2024)
6.4 North America Genetic Engineering Âé¶¹Ô´´ Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genetic Engineering Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Genetic Engineering Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Genetic Engineering Âé¶¹Ô´´ Size by Country (2019-2024)
7.4 Europe Genetic Engineering Âé¶¹Ô´´ Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genetic Engineering Âé¶¹Ô´´ Size (2019-2030)
8.2 Asia-Pacific Genetic Engineering Âé¶¹Ô´´ Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Genetic Engineering Âé¶¹Ô´´ Size by Region (2019-2024)
8.4 Asia-Pacific Genetic Engineering Âé¶¹Ô´´ Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genetic Engineering Âé¶¹Ô´´ Size (2019-2030)
9.2 Latin America Genetic Engineering Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Genetic Engineering Âé¶¹Ô´´ Size by Country (2019-2024)
9.4 Latin America Genetic Engineering Âé¶¹Ô´´ Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genetic Engineering Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East & Africa Genetic Engineering Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Genetic Engineering Âé¶¹Ô´´ Size by Country (2019-2024)
10.4 Middle East & Africa Genetic Engineering Âé¶¹Ô´´ Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Genetic Engineering Introduction
11.1.4 Thermo Fisher Scientific Revenue in Genetic Engineering Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 GenScript
11.2.1 GenScript Company Detail
11.2.2 GenScript Business Overview
11.2.3 GenScript Genetic Engineering Introduction
11.2.4 GenScript Revenue in Genetic Engineering Business (2019-2024)
11.2.5 GenScript Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen Genetic Engineering Introduction
11.3.4 Amgen Revenue in Genetic Engineering Business (2019-2024)
11.3.5 Amgen Recent Development
11.4 Genentech
11.4.1 Genentech Company Detail
11.4.2 Genentech Business Overview
11.4.3 Genentech Genetic Engineering Introduction
11.4.4 Genentech Revenue in Genetic Engineering Business (2019-2024)
11.4.5 Genentech Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Genetic Engineering Introduction
11.5.4 Merck Revenue in Genetic Engineering Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Horizon Discovery Group
11.6.1 Horizon Discovery Group Company Detail
11.6.2 Horizon Discovery Group Business Overview
11.6.3 Horizon Discovery Group Genetic Engineering Introduction
11.6.4 Horizon Discovery Group Revenue in Genetic Engineering Business (2019-2024)
11.6.5 Horizon Discovery Group Recent Development
11.7 Sangamo Therapeutics
11.7.1 Sangamo Therapeutics Company Detail
11.7.2 Sangamo Therapeutics Business Overview
11.7.3 Sangamo Therapeutics Genetic Engineering Introduction
11.7.4 Sangamo Therapeutics Revenue in Genetic Engineering Business (2019-2024)
11.7.5 Sangamo Therapeutics Recent Development
11.8 Transposagen Biopharmaceuticals
11.8.1 Transposagen Biopharmaceuticals Company Detail
11.8.2 Transposagen Biopharmaceuticals Business Overview
11.8.3 Transposagen Biopharmaceuticals Genetic Engineering Introduction
11.8.4 Transposagen Biopharmaceuticals Revenue in Genetic Engineering Business (2019-2024)
11.8.5 Transposagen Biopharmaceuticals Recent Development
11.9 OriGene Technologies
11.9.1 OriGene Technologies Company Detail
11.9.2 OriGene Technologies Business Overview
11.9.3 OriGene Technologies Genetic Engineering Introduction
11.9.4 OriGene Technologies Revenue in Genetic Engineering Business (2019-2024)
11.9.5 OriGene Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher Scientific
GenScript
Amgen
Genentech
Merck
Horizon Discovery Group
Sangamo Therapeutics
Transposagen Biopharmaceuticals
OriGene Technologies
Ìý
Ìý
*If Applicable.